Best of IGCS 2022 Annual Global Meeting-It takes a village: Interdisciplinary management of patients with advanced cervical cancer - Industry Symposium by Seagen Inc. & Genmab

It takes a village: Interdisciplinary management of patients with advanced cervical cancer - Industry Symposium by Seagen Inc. & Genmab

Back to course

Video Transcription

Video Summary

In the video, Dr. Leslie Randall and Dr. Ruthie Solani discuss the use of Tisotamab in treating cervical cancer. Two FDA approvals for cervical cancer treatment have been granted in the past year, highlighting the significance of immunotherapy in improving patient outcomes. Dr. Solani presents a case and discusses treatment options. The video emphasizes the need for close monitoring of ocular toxicity in patients treated with Tisotamab, emphasizing regular eye exams and the use of prophylactic steroid eye drops, vasoconstrictor eye drops, and lubricating eye drops to manage potential eye side effects. Cooperation with an ophthalmologist and ensuring patient understanding and comfort with the treatment are also highlighted. The video underscores Tisotamab as an effective treatment option for cervical cancer patients while emphasizing the importance of addressing and managing ocular toxicity.<br /><br />The video transcript consists of a panel discussion with a patient advocate about Tisotamab as a cervical cancer treatment. The panel discusses the side effects of the drug, specifically ocular toxicity, and the management of these side effects, including the use of artificial tears and contact lenses. The importance of patient education and support is stressed, particularly in terms of sexual health and overall quality of life. The patient advocate shares her personal experience with cervical cancer and highlights the need for clinicians to address the emotional and practical concerns of patients. Nurse navigators and patient advocate groups are also mentioned as valuable resources for support and information. The panel concludes by emphasizing the importance of a multidisciplinary approach and collaboration among healthcare professionals to ensure optimal care for cervical cancer patients.

Keywords

Tisotamab

cervical cancer treatment

FDA approvals

immunotherapy

patient outcomes

ocular toxicity

eye exams

prophylactic steroid eye drops

vasoconstrictor eye drops

lubricating eye drops

ophthalmologist

patient understanding